Literature DB >> 14762446

CD34+ progenitors from MDS patients are unresponsive to SDF-1, despite high levels of SDF-1 in bone marrow plasma.

M Matsuda, Y Morita, H Hanamoto, Y Tatsumi, Y Maeda, A Kanamaru.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14762446     DOI： 10.1038/sj.leu.2403301

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  11 in total

1.  Mesenchymal stromal cells from patients with myelodyplastic syndrome display distinct functional alterations that are modulated by lenalidomide.

Authors:  Ruben A Ferrer; Manja Wobus; Catrin List; Rebekka Wehner; Claudia Schönefeldt; Barbara Brocard; Brigitte Mohr; Martina Rauner; Marc Schmitz; Maik Stiehler; Gerhard Ehninger; Lorenz C Hofbauer; Martin Bornhäuser; Uwe Platzbecker
Journal:  Haematologica       Date:  2013-05-28       Impact factor: 9.941

2.  Impaired expression of DICER, DROSHA, SBDS and some microRNAs in mesenchymal stromal cells from myelodysplastic syndrome patients.

Authors:  Carlos Santamaría; Sandra Muntión; Beatriz Rosón; Belén Blanco; Olga López-Villar; Soraya Carrancio; Fermín M Sánchez-Guijo; María Díez-Campelo; Stela Alvarez-Fernández; María E Sarasquete; Javier de las Rivas; Marcos González; Jesús F San Miguel; María Consuelo Del Cañizo
Journal:  Haematologica       Date:  2012-02-27       Impact factor: 9.941

Review 3.  Myelodysplastic syndromes: revisiting the role of the bone marrow microenvironment in disease pathogenesis.

Authors:  Marc H G P Raaijmakers
Journal:  Int J Hematol       Date:  2012-01-06       Impact factor: 2.490

4.  Serine protease inhibitor kunitz-type 2 is downregulated in myelodysplastic syndromes and modulates cell-cell adhesion.

Authors:  Fernanda Marconi Roversi; Matheus Rodrigues Lopes; João Agostinho Machado-Neto; Ana Leda F Longhini; Adriana da Silva Santos Duarte; Mariana Ozello Baratti; Bruna Palodetto; Flávia Adolfo Corrocher; Fernando Vieira Pericole; Paula de Melo Campos; Patricia Favaro; Fabiola Traina; Sara Teresinha Olalla Saad
Journal:  Stem Cells Dev       Date:  2014-02-18       Impact factor: 3.272

5.  Increase of circulating stromal cell-derived factor-1 in heart failure patients.

Authors:  K Liu; S Yang; M Hou; T Chen; J Liu; B Yu
Journal:  Herz       Date:  2014-11-13       Impact factor: 1.443

6.  The biological behavior of SDF-1/CXCR4 in patients with myelodysplastic syndrome.

Authors:  Rui Yang; Jie Pu; Juan Guo; Feng Xu; Zheng Zhang; Youshan Zhao; Xi Zhang; Shucheng Gu; Chunkang Chang; Xiao Li
Journal:  Med Oncol       Date:  2011-05-10       Impact factor: 3.064

7.  CXCL12+ stromal cells as bone marrow niche for CD34+ hematopoietic cells and their association with disease progression in myelodysplastic syndromes.

Authors:  Shiho Abe-Suzuki; Morito Kurata; Shinya Abe; Iichiroh Onishi; Susumu Kirimura; Manami Nashimoto; Toshihiko Murayama; Michihiro Hidaka; Masanobu Kitagawa
Journal:  Lab Invest       Date:  2014-09-08       Impact factor: 5.662

8.  Expansion of myeloid derived suppressor cells correlates with number of T regulatory cells and disease progression in myelodysplastic syndrome.

Authors:  Astrid Olsnes Kittang; Shahram Kordasti; Kristoffer Evebø Sand; Benedetta Costantini; Anne Marijn Kramer; Pilar Perezabellan; Thomas Seidl; Kristin Paulsen Rye; Karen Marie Hagen; Austin Kulasekararaj; Øystein Bruserud; Ghulam J Mufti
Journal:  Oncoimmunology       Date:  2015-06-24       Impact factor: 8.110

Review 9.  Mesenchymal Stem and Progenitor Cells in Normal and Dysplastic Hematopoiesis-Masters of Survival and Clonality?

Authors:  Lisa Pleyer; Peter Valent; Richard Greil
Journal:  Int J Mol Sci       Date:  2016-06-27       Impact factor: 5.923

10.  Expression patterns of chemokine receptors on circulating T cells from myelodysplastic syndrome patients.

Authors:  Kristoffer Evebø Sand; Kristin Paulsen Rye; Bård Mannsåker; Oystein Bruserud; Astrid Olsnes Kittang
Journal:  Oncoimmunology       Date:  2013-02-01       Impact factor: 8.110
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.